Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancer Letters|December 30, 2006
Ginkgo biloba and ovarian cancer prevention: epidemiological and biological evidenceBin Ye, Margarita Aponte, Yan Dai, et al.
Cancer Research|July 18, 2008
Activation of platelet-activating factor receptor and pleiotropic effects on tyrosine phospho-EGFR/Src/FAK/paxillin in ovarian cancerMargarita Aponte, Wei Jiang, Montaha Lakkis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Proteomic-based discovery and characterization of glycosylated eosinophil-derived neurotoxin and COOH-terminal osteopontin fragments for ovarian cancer in urineBin Ye, Steven Skates, Samuel C Mok, et al.
Reproductive Biology and Endocrinology : RB&E|June 26, 2010
Activated networking of platelet activating factor receptor and FAK/STAT1 induces malignant potential in BRCA1-mutant at-risk ovarian epitheliumLifang Zhang, Dan Wang, Wei Jiang, et al.
European Journal of Cancer (Oxford, England : 1990)|November 21, 2009
Autoantibody profiling to identify biomarkers of key pathogenic pathways in mucinous ovarian cancerLiangdan Tang, Junzheng Yang, Shu-Kay Ng, et al.
The Journal of Pathology|September 20, 2018
Primordial germ cells as a potential shared cell of origin for mucinous cystic neoplasms of the pancreas and mucinous ovarian tumorsKevin M Elias, Petros Tsantoulis, Jean-Christophe Tille, et al.
Frontiers in Pain Research (Lausanne, Switzerland)|March 27, 2025
Exploring the value of a well-established conditioned pain modulation paradigm in women: a Translational Research in Pelvic Pain (TRiPP) studyLysia Demetriou, Danielle Perro, Lydia Coxon, et al.
Cancer Prevention Research (Philadelphia, Pa.)|March 5, 2011
A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancerClaire S Zhu, Paul F Pinsky, Daniel W Cramer, et al.
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
Nature Genetics|March 14, 2023
The genetic basis of endometriosis and comorbidity with other pain and inflammatory conditionsNilufer Rahmioglu, Sally Mortlock, Marzieh Ghiasi, et al.
Pageof 2